Literature DB >> 2783446

Increased proportion of B cell hybridomas secreting monoclonal antibodies of desired specificity in cultures containing macrophage-derived hybridoma growth factor (IL-6).

R Bazin1, R Lemieux.   

Abstract

The addition of macrophage feeder cells or conditioned medium has been shown to increase the yield of murine hybridomas obtained after the fusion of myeloma cells and activated B lymphocytes. It has been shown recently that the conditioned medium contains a growth factor (HGF) active on newly formed hybridomas and that the human HGF is similar to B cell stimulatory factor 2 which can induce the synthesis of antibodies in transformed B cells. We have compared in several fusion experiments the stimulatory effects of HGF both on the yield of hybridomas and on the number of antibody-secreting hybridomas. The results obtained clearly showed that while the stimulatory effect of HGF on the yield of growth-positive wells was variable and sometimes barely detectable, the proportion of growth-positive wells containing monoclonal antibodies was consistently much higher in the HGF-containing cultures. These results suggest that the majority of the antibody-secreting newly formed hybridomas are sensitive to HGF and indicate that HGF is a very useful culture supplement for the generation of a high number of antibody-producing hybridomas even if it may not increase significantly the yield of viable hybridomas.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783446     DOI: 10.1016/0022-1759(89)90210-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Genetical and immunological analysis of recent Asian type A and O foot-and-mouth disease virus isolates.

Authors:  B Freiberg; M M Rahman; O Marquardt
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

2.  A fraction of the mRNA 5' cap-binding protein, eukaryotic initiation factor 4E, localizes to the nucleus.

Authors:  F Lejbkowicz; C Goyer; A Darveau; S Neron; R Lemieux; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

3.  The Hsp70 and TRiC/CCT chaperone systems cooperate in vivo to assemble the von Hippel-Lindau tumor suppressor complex.

Authors:  Mark W Melville; Amie J McClellan; Anne S Meyer; Andre Darveau; Judith Frydman
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

4.  The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties.

Authors:  G N Barber; S Thompson; T G Lee; T Strom; R Jagus; A Darveau; M G Katze
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

5.  A minor alternative transcript of the fumarylacetoacetate hydrolase gene produces a protein despite being likely subjected to nonsense-mediated mRNA decay.

Authors:  Natacha Dreumont; Antonella Maresca; Jean-François Boisclair-Lachance; Anne Bergeron; Robert M Tanguay
Journal:  BMC Mol Biol       Date:  2005-01-07       Impact factor: 2.946

6.  NAb-seq: an accurate, rapid, and cost-effective method for antibody long-read sequencing in hybridoma cell lines and single B cells.

Authors:  Hema Preethi Subas Satish; Kathleen Zeglinski; Rachel T Uren; Stephen L Nutt; Matthew E Ritchie; Quentin Gouil; Ruth M Kluck
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

7.  Enhancement of hybridoma formation, clonability and cell proliferation in a nanoparticle-doped aqueous environment.

Authors:  Natalie Gavrilov-Yusim; Ekaterina Hahiashvili; Marina Tashker; Victoria Yavelsky; Ohad Karnieli; Leslie Lobel
Journal:  BMC Biotechnol       Date:  2008-01-14       Impact factor: 2.563

Review 8.  Exploring the native human antibody repertoire to create antiviral therapeutics.

Authors:  S K Dessain; S P Adekar; J D Berry
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

Review 9.  From bench to cageside: Risk assessment for rodent pathogen contamination of cells and biologics.

Authors:  Norman C Peterson
Journal:  ILAR J       Date:  2008
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.